VitamFero S.A.

https://www.vitamfero.com

Created in 2005 and having just completed a significant raise of 1.1 M€, VitamFero (www.vitamfero.com) exploits the breakthroughs jointly obtained and patented by CNRS, INRA and Université François Rabelais in Tours (France) in the domain of antiparasite vaccines, an area where needs are still largely unmet. VitamFero is built on a strong and validated scientific basis, based on the development of living parasite strains (i.e. Toxoplasma gondii, …), attenuated by complete and targeted deletion of virulence genes. *

	Start	2005-10-27 established
	Industry	animal health
	Person	Breton, Pascal (VitamFero 201106 CEO)
	Person 2	Sèche, Edouard (VitamFero 201107 CSO)

	Region	Évry, Essonne
	Country	France
	Street	4 rue Pierre Fontaine Génopôle
	City	91058 Évry Cedex
	Tel	+33-6-8265-4769
		Address record changed: 2020-12-02

Basic data	Employees	A: 1 to 10 (2013-01-01)
	Currency	EUR
	Annual sales	64,000 (turnover (2012) 2012-12-31)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]